Nav: Home

The EBMT is launching the 1st Pharmacist Day, a unique initiative in Europe

March 24, 2016

Key leaders in the field of haematopoetic stem cell transplantation (HSCT) will highlight the challenges faced by clinical oncology pharmacists involved in Stem Cell Transplantation and haematology in general. This day-long session will take place on Tuesday 5 April on the occasion of the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation that will welcome more than 4,500 delegates in the host city of Valencia, Spain.

Close co-operation and the increasing integration of experienced pharmacist in HSCT unit ensure all transplant patients receive high-quality pharmaceutical care and patient satisfaction. As an example, the pharmacist ensures the clinical appropriateness and safety of all medications, including chemotherapy orders, performing medication reconciliation, educating patients on their medications and monitoring toxicities and patient results. The clinical oncology pharmacist also works with the SCT unit on updating standards of practice of the SCT program.

Dr. Miguel Ángel Sanz, the EBMT Congress President, highlights that: "The EBMT has decided to include the pharmacist in the scientific programme of the Annual Meeting as a response of pharmacists' demands and as recognition of their increasing patient-centered care. Dr. Sanz adds: "The EBMT recognises the pharmacist as an integral member of the multidisciplinary SCT team who provides a variety of pharmacy and educational services to both the healthcare team and the patient."

This original cutting-edge program includes sessions that will cover topics such as: how clinical oncology pharmacists participate in Stem Cell Transplantation; perspectives in SCT; drug dosing and monitoring; side effects of novel therapies and promote general learning.

The Spanish Society of Hospital Pharmacy (SEFH) and its oncology pharmacist group (GEDEFO) have been working together with the EBMT in the development of this event. "Pharmacists involved in Stem Cell Transplantation and haematology are very enthusiastic and motivated professionals looking for increasing their expertise. We are delighted to welcome them to what promises to be a highly educational and successful initiative." says Dra. Irene Mangues, National Coordinator of GEDEFO.

For further information about the 1st Pharmacist Day, please visit the EBMT Annual Meeting website: http://www.ebmt2016.org and view the online programme: https://b-com.mci-group.com/EventProgramme/EBMT2016.aspx
-end-
About the European society for Blood and Marrow Transplantation (EBMT)

The EBMT is a not-for-profit medical and scientific organisation established in 1974. It is dedicated to fighting life-threatening blood cancers and diseases and improving patients' lives. The EBMT Members - more than 4,000 physicians, nurses, scientists and other healthcare professionals - participate in a unique collaborative network of peers involved in haematopoietic stem cell transplantation (HSCT) and cellular therapy research. The membership encompasses at least 600 centres who are performing or are involved in HSCT in more than 60 countries. The EBMT holds a central role in performing co-operative studies and disseminating state-of-the-art knowledge aimed at increasing survival rates and enhancing the quality of life of patients with life-threatening blood cancers and diseases. For further information about the EBMT, please visit the website: http://www.ebmt.org and follow us on Twitter: @TheEBMT

European Society for Blood and Marrow Transplantation

Related Side Effects Articles:

Popular prostate drug linked to serious side effects
Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction.
Previously unpublished trial data explain effects and side effects of key MS drug
Through a Freedom of Information request to the European Medicines Agency, researchers from Queen Mary University of London (QMUL) gained access to the phase III trial datasets of Alemtuzumab, and publish new insights (JAMA Neurology) into the drastic response of the immune system in patients with MS.
Painkillers without dangerous side effects
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Measuring patients' muscles to predict chemotherapy side effects
Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center report in the journal Clinical Cancer Research that measuring patients' muscle mass and quality could potentially help doctors better identify patients at high risk for toxic side effects that could require hospitalizations.
Ground-breaking research on the side effects of therapy
While many people who suffer from depression and anxiety are helped by seeing a psychologist, others don't get better or actually get worse.
Naturally occurring symptoms may be mistaken for tamoxifen side-effects
Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they suffered nausea and vomiting, according to new data presented at the San Antonio Breast Cancer Symposium.
An appetite suppressant with side effects
Neurogeneticists from the University of Würzburg have discovered a peptide in Drosophila that has a strong impact on the fly's feeding and sleeping habits.
Dopamine receptor blockade seen as cause for antipsychotic drug side-effects
University of California, Irvine scientists led by Emiliana Borrelli and colleagues have discovered the key cellular mechanism that underlies the antipsychotic-induced parkinsonism -- which includes involuntary movements, tremors and other severe physical conditions.
Predicting potential pharma side effects
A computer program that can predict whether or not a given pharmaceutical will have worrying side effects has been developed by researchers in the USA.
Reduced side effects from ECT for those with severe depression
Despite its effectiveness, use of ECT remains limited due to concerns about side effects.

Related Side Effects Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.